1. Home
  2. NMTC vs ABVC Comparison

NMTC vs ABVC Comparison

Compare NMTC & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$3.35

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Logo ABVC BioPharma Inc.

ABVC

ABVC BioPharma Inc.

HOLD

Current Price

$1.31

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMTC
ABVC
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.2M
34.6M
IPO Year
2010
2009

Fundamental Metrics

Financial Performance
Metric
NMTC
ABVC
Price
$3.35
$1.31
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$11.90
N/A
AVG Volume (30 Days)
25.5K
117.5K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
80.43
7.14
EPS
N/A
N/A
Revenue
$9,097,692.00
$509,589.00
Revenue This Year
N/A
N/A
Revenue Next Year
$31.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
163.47
N/A
52 Week Low
$0.55
$0.88
52 Week High
$5.40
$4.02

Technical Indicators

Market Signals
Indicator
NMTC
ABVC
Relative Strength Index (RSI) 41.27 53.75
Support Level $0.69 $1.18
Resistance Level $4.87 $1.47
Average True Range (ATR) 0.20 0.12
MACD -0.02 -0.00
Stochastic Oscillator 36.75 44.14

Price Performance

Historical Comparison
NMTC
ABVC

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Share on Social Networks: